tetano
Editor, Senior Moderator
CJC Open
. 2021 Dec 9.
doi: 10.1016/j.cjco.2021.12.002. Online ahead of print.
Recurrence of myopericarditis following mRNA COVID-19 vaccination in a male adolescent
Tomohiko C Umei[SUP] 1 [/SUP], Yoshikazu Kishino[SUP] 1 [/SUP], Yasuyuki Shiraishi[SUP] 1 [/SUP], Taku Inohara[SUP] 1 [/SUP], Shinsuke Yuasa[SUP] 1 [/SUP], Keiichi Fukuda[SUP] 1 [/SUP]
Affiliations
Abstract
Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It has spread worldwide, resulting in health and economic crises. Vaccination against SARS-CoV-2 infection is considered a valid prevention measure to control this pandemic. There have been reports of cases of myopericarditis following mRNA COVID-19 vaccination. We present a case of a 20-year-old man with recurrent myopericarditis following an initial episode of influenza virus-induced myopericarditis and after receiving a second dose of the mRNA-1273 Moderna COVID-19 vaccine. Careful attention should be paid to patients with a history of myocarditis following COVID-19 vaccination.
Keywords: COVID-19; myopericarditis; vaccine.
. 2021 Dec 9.
doi: 10.1016/j.cjco.2021.12.002. Online ahead of print.
Recurrence of myopericarditis following mRNA COVID-19 vaccination in a male adolescent
Tomohiko C Umei[SUP] 1 [/SUP], Yoshikazu Kishino[SUP] 1 [/SUP], Yasuyuki Shiraishi[SUP] 1 [/SUP], Taku Inohara[SUP] 1 [/SUP], Shinsuke Yuasa[SUP] 1 [/SUP], Keiichi Fukuda[SUP] 1 [/SUP]
Affiliations
- PMID: 34904134
- PMCID: PMC8656213
- DOI: 10.1016/j.cjco.2021.12.002
Abstract
Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It has spread worldwide, resulting in health and economic crises. Vaccination against SARS-CoV-2 infection is considered a valid prevention measure to control this pandemic. There have been reports of cases of myopericarditis following mRNA COVID-19 vaccination. We present a case of a 20-year-old man with recurrent myopericarditis following an initial episode of influenza virus-induced myopericarditis and after receiving a second dose of the mRNA-1273 Moderna COVID-19 vaccine. Careful attention should be paid to patients with a history of myocarditis following COVID-19 vaccination.
Keywords: COVID-19; myopericarditis; vaccine.